Nguyen ML, Sumbry A, Reddy D, Harvey K, Gunthel C, Wang W, Tsui C, Ziemer D, del Rio C, Young JL Increased Incidence of Non AIDS-related Malignancies and.

Slides:



Advertisements
Similar presentations
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Advertisements

Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA Eli Rosenberg Patrick Sullivan, Colleen Kelley, Travis Sanchez, Nicole.
HIV and STI Department - Centre for Infections Predictors of non-AIDS related death in a national cohort of HIV-diagnosed adults Meaghan Kall, Ruth Smith,
NCD Complications in HIV Patients Esteban Martinez Hospital Clínic University of Barcelona Barcelona SPAIN Washington D.C., USA,
GRADY HEALTH SYSTEM Deepa Reddy 1, Anitra Sumbry 1, David Reznik 2, Clifford Gunthel 1, Judy Mc Guire 2, Minh Ly Nguyen 1 1 Emory University School of.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER HIV and Non Hodgkin Lymphoma Virginia C. Broudy, MD September 25, 2014 Presentation prepared by: Presenter.
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
Causes of Death and Mortality Trends among Utah HIV/AIDS Cases, Anne Burke, MS, Matthew S. Mietchen, MPH, David Jackson, MPH, Allyn K. Nakashima,
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
BACKGROUND METHODS Subjects were recruited by the Asian Pacific Health Foundation in San Diego focusing on areas with strong representation of Asian Americans.
The National Program of Cancer Registries: Enhancing Cancer Incidence Data … Hannah K. Weir, PhD Division of Cancer Prevention and Control Centers for.
Should We be Measuring Mortality in HIV Clinical Programs? September 13 th, 2012 Steven Johnson MD Director, University of Colorado HIV/AIDS Clinical Program;
Factors associated with Mortality in the Study of Fat Redistribution and Metabolic Change in HIV infection Leslie Modrich 1, Rebecca Scherzer 1,2, Andrew.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Fatal and Non-fatal Hepatic Failure in HIV-infected versus HIV-uninfected Persons Enrolled in Kaiser Permanente California (KP), a Large Managed Care Organization.
Responding to Reviews of Submitted Manuscripts Ron D. Hays, Ph.D. UCLA GIM & HSR March 2, 2015 HPM 214, Los Angeles, CA.
National Program of Cancer Registries
Risk Factors for Development of Anal Cancer in HIV-Infected Men Phillip Cole, M.D. 1, Wendy Leyden, M.P.H. 2, Michael Silverberg, Ph.D., M.P.H. 2 1 UC.
HIV i-Base: SMART Study & CROI Feedback UK-CAB - Feb 2006 UK-CAB 24 February 2006 CROI Feedback: SMART Study Simon Collins.
Social Disparities and Mortality in a Large Metropolitan HIV Cohort Peter Messeri 1 Mary Ann Chiasson 2 1 Columbia University, Mailman School of Public.
#735 KA Lichtenstein 1, C Armon 2, K Buchacz 3, AC Moorman 3, KC Wood 2, JT Brooks 3, and the HOPS Investigators 1 University of Colorado Health Sciences.
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
David Dowdy, Elvin Geng, Katerina Christopoulos, James Kahn, C. Bradley Hare, Daniel Wlodarczyk, Diane Havlir Internal Medicine Residency Program, UCSF.
INTRODUCTION Evaluation of Outcomes in Patients Starting Antiretroviral Therapy During Hospitalization Leigh E. Efird, PharmD 1, Manish Patel, PharmD 1,
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.
Changing Epidemiology of Opportunistic Infections in the HAART Era International AIDS Society 2012 Henry Masur MD Chief, Critical Care Medicine Department.
Results Compliance with Breast Cancer Screening Guidelines in the HIV Clinic: A Quality Improvement Tool E. Patrozou M.D., E. Christaki M.D., L. Hicks.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Correlates of HIV incidence among black men who have sex with men in 6 U.S. cities (HPTN 061) B. KOBLIN, K. MAYER, S. ESHLEMAN, L. WANG, S. SHOPTAW, C.
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Reduced Lung Cancer Mortality Risk Among Breast Cancer Patients Treated With Anti- Estrogens Rapiti E et al. SABCS 2009;Abstract 35.
A Survival Comparison between HIV+ U.S.-born Latinos and Foreign-born Latinos in Houston, Texas Raouf Arafat, MD, MPH, Adebowale Awosika- Olumo.
Cancer Linkage With an HIV/STD Registry: Describing the Cancer Morbidity Among HIV/AIDS Patients and Opportunities for Improving Surveillance June 5, 2007.
Malignancies in Young People Sophie Herbert, Alison Barbour, Eva Jungmann, Caroline Foster on behalf of the HIV Young Persons Network (HYPNET)
Slideset on: Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the.
Date of download: 6/3/2016 From: U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected.
Meg Watson, MPH Recent Trends in HPV-Associated Cancers among Women Epidemiology and Applied Research Branch Division of Cancer Prevention and Control.
Problems of HIV Infection in the HAART Era Akihiko Suganuma M.D. Tokyo Metropolitan Komagome Hospital Department of Infectious Diseases.
Cancer Incidence and Mortality among Adolescence and Young Adults Age in Florida Youjie Huang, MD, DrPH Tara Hylton, MPH Florida Department of Health,
F. 정 회 훈 Am J Gastroenterol 2012;107:46-52 Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy:
Demographic and Behavioral Differences between Latino and non-Latino Patients Attending Baltimore City STD Clinics, Renee M. Gindi 1, Kathleen.
What does the data tell us? Colorectal CANCER IN NEVADA
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
Emory University School of Medicine Department of Medicine
BACKGROUND Cancer in Latin American and Caribbean HIV+ populations has not been studied comprehensively. CCASAnet includes sites from Argentina, Brazil,
Melanie L. Fritza Ronald J. Lubelchek, MD a, b, c*
Description of In Situ Tumors Reported to Cancer Registries,
San Francisco Department of Public Health
Focus on prostate cancer
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
and total thyroid cancer mortality (USA) from 1993 to 2012
Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) SL Fultz, MD, MPH CH Chang, PhD AA.
BACKGROUND Cancer in Latin American and Caribbean HIV+ populations has not been studied comprehensively. CCASAnet includes sites from Argentina, Brazil,
Trends in survival from metastatic lung cancer in California,
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group  Alain Makinson,
Focus on prostate cancer
Presentation transcript:

Nguyen ML, Sumbry A, Reddy D, Harvey K, Gunthel C, Wang W, Tsui C, Ziemer D, del Rio C, Young JL Increased Incidence of Non AIDS-related Malignancies and Earlier Age at Occurrence In an Urban Outpatient HIV Clinic INACS

Current SEER Registries 6 Cities – Atlanta – Detroit – LA – San Francisco – San Jose – Seattle 11 States – Alaska natives – Arizona Indians – California – Connecticut – Hawai – Iowa – Kentucky – Louisiana – New Jersey – New Mexico – Utah

Background AIDS and cancer registries linkage compared to 17 SEER regirstries ( ) 1 HOPS and ASD [compared to 17 SEER Registries] (1992 – 2003) 2 Johns Hopkins HIV/AIDS Cohort [compared to Detroit cancer registry] ( ) 3 Increase in incidence in : ano-rectal cancer,hepatocellular cancer, Hodgkin lymphoma,lung cancer and head and neck cancer 1-Engels et al. AIDS 2006: 20: Patel et al. Ann Int Med 2008:148: Long et al. AIDS 2009: 22:

Background HIV/AIDS cancer match study versus 17 SEER registries ( ) 1 – People with HIV getting cancer at an earlier age – After accounting for underlying population age distributions, the authors found either no difference or very small differences in the observed and expected ages at diagnosis for most cancers 1-Shiels et al. CROI2010

INACS Objective: To investigate the incidence of non-AIDS defining cancers (NADC) and age at diagnosis of NADC in the HAART era in an outpatient HIV/AIDS urban clinic in the southeastern USA.

Methods Setting: Grady Infectious Disease Program (IDP) at the Ponce de Leon Health Center (Ponce Clinic) Design: Retrospective study of 8,300 patients ( ). Incidence was examined using Poisson analysis. Data sources: - Clinic visit records matched by name, medical records and birth date to Grady Health System cancer registry. - Included are all patients who contributed person time from 1/1/2000 until the earliest of the following: cancer diagnosis, death, loss to follow up or 12/31/2007.

Ponce Clinic Demographics Study Sample N= 8,300 Males n = 6,189 (75%) Females n= 2,111 (25%) Age (mean) Race Black Caucasian Hispanic Other 4495(73%) 1379 (22%) 209 (3%) 106 (2%) 1849 (88%) 150 ( 7%) 66 (3%) 46 (2%) Year of enrollment 2000 – – (59%) 2517 (41%) 1238 (59%) 873 (41%) Mean person-years attending clinic

Distribution of Cancer Cases in Study Cohort Total Cancer Cases N=512 AIDS-Defining Cancer N=320 Non AIDS-Defining Cancer N=192 Kaposi Sarcoma (182) Non-Hodgkin Lymphoma (124) Cervical Cancer (14) Lung Cancer(40) Anal Rectal Scc(24) Head And Neck Cancer Scc(22) Prostate Cancer(18) Hodgkin Lymphoma(16) Liver Cancer (10) Breast Cancer (11) Other (51)

Cancer Patient Demographics Cancer Patients N=186/8300 (2.2%) Males N= 142/6189 (2.3%) 8.6/1000 pt-years Females n= 44/2111(2.1%) 8.7/1000 pt-years Race: Black Caucasian 112(79%) 30(21%) 40(91%) 4 (9%) Age at HIV diagnosis37.9 ± ± 12 Age at cancer diagnosis46.9 ± ± 10.9 Nadir CD4 count (cells/mm3)129.4 ± ± CD4 count at cancer diagnosis263.4 ± ± 250 On HAART at cancer diagnosisNo: 63(44%) Yes: 74(52%) No: 26(60%) Yes: 18(40%) Undetectable VL at cancer diagnosis14/81 (17.3%)3/28 (10.7%) Average years at IDP to cancer diagnosis 3.9± ± 2.96

Cancers incidence in Ponce Clinic Patients Compared to Atlanta Metro Area CancersNSIR * p- value Anal/rectal SCC Hodgkin’s Lymphoma Hepatocellular cancer Head and neck cancer SCC Lung cancer Breast cancer Prostate cancer < *SIR=standardized incidence ratio =number observed cancers at IDP/ number expected cancers standardized by age, race and gender

Average Age at NADC Diagnosis IDP versus Metro Atlanta population CancerAge at cancer IDP Age at cancer Atlanta Anal/Rectal SCC Hodgkin’s Lymphoma * 2 Liver Head and Neck Lung Breast Prostate *not statistically different at p<0.05

Strengths and limitations Strengths: – Relatively homogeneous cohort: patients all very immunosuppressed, came from the same clinic Limitations: – Retrospective study – missing data, inability to follow up intriguing questions, inability to control for individual risk factors such as smoking, CD4 count, viral load, or other cancer risk factors – Underestimation

Conclusion Similar to published studies, IDP patients had a higher incidence of NADC than the metro Atlanta general population. Cancers with the highest SIR were those associated with an infectious etiology (anal SCC, HL, liver cancer and head and neck SCC). Interestingly, the rate for anorectal SCC is 68 times that of the general population. IDP patients are getting those cancers at an earlier age than the metro Atlanta general population. Cancer screening in HIV infected patients should be considered at an earlier age than in the general population.

Acknowledgments Emory University: Carlos del Rio, MD Kevin J Farrell, MD Mitchell Klein, PhD Jeffrey Lennox, MD John L. Young, PhD Yun W Wang, PhD CFAR : Kimberley Hagen, PhD CFAR 03, NIH supplement to P30 AI INACS team: Clifford Gunthel, MD Kira Harvey, BA Deepa Reddy, MD Anitra Sumbry, MPH Circe Tsui, BS Grady Health System: Dorothy Ziemer, MSW IDP medical records staff Grady cancer registry staff IDP patients

Thank you for your attention

Cancers incidence in Ponce Clinic Patients Compared to 17 SEER Registries CancersNSIR * p- value Anal/rectal SCC Hodgkin’s Lymphoma Hepatocellular cancer Head and neck cancer SCC Lung cancer Breast cancer Prostate cancer < *SIR=standardized incidence ratio =number observed cancers at IDP/ number expected cancers standardized by age, race and gender